Company Filing History:
Years Active: 1997-1999
Title: Innovations in Bioreactor Technology by Scott Lyle Nyberg
Introduction
Scott Lyle Nyberg is an accomplished inventor based in St. Louis Park, MN (US). He has made significant contributions to the field of bioreactor technology, particularly in the maintenance of animal cells for medical applications. With a total of 2 patents, his work focuses on enhancing cell viability and function for therapeutic purposes.
Latest Patents
Nyberg's latest patents include innovative methods for maintaining cells for an extended time through entrapment in a contracted bioreactor. One of his notable inventions is a method for supporting hepatocyte function and viability to treat patients suffering from hepatic failure. This method utilizes a bioreactor that contains a feed and waste chamber, as well as a cell chamber separated by a selectively permeable membrane. Within the cell chamber, a biocompatible contracted three-dimensional gel matrix entraps animal cells, allowing for the preservation of tissue-specific function. The bioreactor is designed to achieve three distinct zones using only two chambers, which can be configured as either hollow fiber or flat-bed systems.
Another significant patent involves a bioreactor apparatus that serves as a bioartificial liver. This device comprises two chambers, where the cell chamber contains a biocompatible matrix that supports the growth and function of hepatocytes. The design allows for nutrient media perfusion and waste removal, enhancing the overall efficacy of the bioreactor in medical applications.
Career Highlights
Nyberg is affiliated with the University of Minnesota, where he continues to advance research in bioreactor technology. His work has implications for improving treatments for liver diseases and enhancing the production of cell-based therapies.
Collaborations
Some of his notable coworkers include Wei-Shou Hu and Frank B Cerra, who have contributed to the research and development of bioreactor systems alongside Nyberg.
Conclusion
Scott Lyle Nyberg's innovative work in bioreactor technology represents a significant advancement in the field of medical research. His patents reflect a commitment to improving cell viability and function, which could lead to better therapeutic outcomes for patients.